Stock MoversStock Movers

CVC Drops, Mankind Rises, Revolution Medicines Drops on Merck News

View descriptionShare

On this episode of Stock Movers:
- CVC (CVC) shares drop after the company agreed to buy Marathon Asset Management in a cash and equity transaction with a base consideration valued at as much as $1.2 billion.
- Mankind (MNKD) shares rise after the FDA approved an update to the company’s inhaled insulin, revising recommendations for the starting mealtime dosage.
- Revolution Medicines (RVMD) shares drop on news Merck is no longer in talks to acquire biotech firm.

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Stock Movers

Listen for five-minute conversations on today's biggest winners and losers in the stock market.  Su 
Social links
Follow podcast
Recent clips
Browse 1,978 clip(s)